News Guest User 21/2/25 Guest User 21/2/25 National recognition for cardiovascular research translation Read More Guest User 10/10/24 Guest User 10/10/24 Infensa researchers nominated for a national university award Read More Guest User 7/10/24 Guest User 7/10/24 Infensa drug candidate receives $17.8M funding to advance to clinical trials Read More Guest User 30/8/24 Guest User 30/8/24 Infensa wins KE Select Emerging Innovator of the Year at Life Sciences Queensland awards Read More Guest User 30/7/24 Guest User 30/7/24 Infensa Bioscience selected as a finalist for the 2024 KE Select Emerging Innovator Award by Life Sciences Queensland Read More Guest User 23/5/24 Guest User 23/5/24 Infensa CSO and co-founder Professor Glenn King elected a Fellow of the Australian Academy of Science Read More Guest User 5/3/24 Guest User 5/3/24 Brisbane startup Infensa spins medical miracle from spider venom Read More Guest User 14/12/23 Guest User 14/12/23 Infensa scientists publish in European Heart Journal showing efficacy of lead drug candidate when administered at relevant timepoints in preclinical models of moderate and severe myocardial infarction Read More Guest User 17/11/23 Guest User 17/11/23 Infensa CEO Mark Smythe received the LSQ McCullough Robertson Industry Excellence Award from Life Sciences Queensland in recognition of his major contributions to the Queensland life sciences industry Read More Guest User 16/10/23 Guest User 16/10/23 Infensa CSO and co-founder Professor Glenn King received the Prime Minster’s Prize for Innovation, the highest honour for science translation in Australia Read More Guest User 7/7/22 Guest User 7/7/22 The Translational Research Institute welcomes new startup Infensa Bioscience Read More Guest User 4/7/22 Guest User 4/7/22 Australian Financial Review: Aussie start-up using funnel web venom to save lives scores $23 million Read More Guest User 29/7/21 Guest User 29/7/21 Fraser Island funnel web spider venom shows promise for heart-attack treatment Read More Guest User 20/7/21 Guest User 20/7/21 Deadly spider’s venom could someday help heart attack victims, Australian scientists say Read More Guest User 16/7/21 Guest User 16/7/21 Deadly venom from funnel-web spider found only in Queensland could contain life-saving heart attack treatment Read More News Guest User 16/7/21 News Guest User 16/7/21 Death disruptor: how an Australian funnel-web spider may help human hearts Read More Guest User 16/7/21 Guest User 16/7/21 One of the world's deadliest spider venoms could help heart attack patients Read More Guest User 16/7/21 Guest User 16/7/21 Aussie scientists see life-saving potential in spider venom Read More Guest User 16/7/21 Guest User 16/7/21 Stopping 'death signal': Scientists look to repair hearts using deadly spider venom Read More Guest User 15/7/21 Guest User 15/7/21 Infensa scientists show efficacy of lead drug candidate in preclinical models of myocardial infarction and heart transplantation Read More
Guest User 21/2/25 Guest User 21/2/25 National recognition for cardiovascular research translation Read More
Guest User 10/10/24 Guest User 10/10/24 Infensa researchers nominated for a national university award Read More
Guest User 7/10/24 Guest User 7/10/24 Infensa drug candidate receives $17.8M funding to advance to clinical trials Read More
Guest User 30/8/24 Guest User 30/8/24 Infensa wins KE Select Emerging Innovator of the Year at Life Sciences Queensland awards Read More
Guest User 30/7/24 Guest User 30/7/24 Infensa Bioscience selected as a finalist for the 2024 KE Select Emerging Innovator Award by Life Sciences Queensland Read More
Guest User 23/5/24 Guest User 23/5/24 Infensa CSO and co-founder Professor Glenn King elected a Fellow of the Australian Academy of Science Read More
Guest User 5/3/24 Guest User 5/3/24 Brisbane startup Infensa spins medical miracle from spider venom Read More
Guest User 14/12/23 Guest User 14/12/23 Infensa scientists publish in European Heart Journal showing efficacy of lead drug candidate when administered at relevant timepoints in preclinical models of moderate and severe myocardial infarction Read More
Guest User 17/11/23 Guest User 17/11/23 Infensa CEO Mark Smythe received the LSQ McCullough Robertson Industry Excellence Award from Life Sciences Queensland in recognition of his major contributions to the Queensland life sciences industry Read More
Guest User 16/10/23 Guest User 16/10/23 Infensa CSO and co-founder Professor Glenn King received the Prime Minster’s Prize for Innovation, the highest honour for science translation in Australia Read More
Guest User 7/7/22 Guest User 7/7/22 The Translational Research Institute welcomes new startup Infensa Bioscience Read More
Guest User 4/7/22 Guest User 4/7/22 Australian Financial Review: Aussie start-up using funnel web venom to save lives scores $23 million Read More
Guest User 29/7/21 Guest User 29/7/21 Fraser Island funnel web spider venom shows promise for heart-attack treatment Read More
Guest User 20/7/21 Guest User 20/7/21 Deadly spider’s venom could someday help heart attack victims, Australian scientists say Read More
Guest User 16/7/21 Guest User 16/7/21 Deadly venom from funnel-web spider found only in Queensland could contain life-saving heart attack treatment Read More
News Guest User 16/7/21 News Guest User 16/7/21 Death disruptor: how an Australian funnel-web spider may help human hearts Read More
Guest User 16/7/21 Guest User 16/7/21 One of the world's deadliest spider venoms could help heart attack patients Read More
Guest User 16/7/21 Guest User 16/7/21 Aussie scientists see life-saving potential in spider venom Read More
Guest User 16/7/21 Guest User 16/7/21 Stopping 'death signal': Scientists look to repair hearts using deadly spider venom Read More
Guest User 15/7/21 Guest User 15/7/21 Infensa scientists show efficacy of lead drug candidate in preclinical models of myocardial infarction and heart transplantation Read More
